The global malaria diagnostics market size is projected to reach USD 998.85 million by 2026 expanding at a CAGR of 5.4%, according to a new report by Grand View Research, Inc. Rising prevalence of the tropical disease in endemic countries, development of novel diagnostic techniques, and rising investments by regional governments and private investors are expected to propel market growth. Malaria is one of the most widespread life-threatening diseases, commonly occurring in the tropical and subtropical regions due to changing climate, low economic growth, underdeveloped healthcare infrastructure, and lack of access to advanced treatment.
Increasing
number of government initiatives and investments by market participants are
also anticipated to fuel market growth in the near future. A large number of
malarial elimination programs are being undertaken by major companies to reduce
the disease prevalence. For instance, Novartis’s Malaria Initiative was aimed
at facilitating malaria elimination and control.Along with various
organizations, the company has provided non-profit treatment to 750 million
people across 60 countries. Thus, such initiatives are anticipated to
facilitate the development of novel technologies and aid in market penetration.
Full Research Report On Malaria Diagnostics Market Visit Here:
https://www.grandviewresearch.com/industry-analysis/malaria-diagnostics-market
Further key
findings from the study suggest:
- Conventional usage of microscopic
examination for detection of malarial parasite has driven the microscopy
technology segment
- RDTs are anticipated to
account for the largest revenue share owing to ease of usage, convenience,
and rapid diagnosis
- Molecular diagnostic tests
is projected to be the fastest-growing technology segment during the
forecast period owing to their accuracy and capability of detecting low
parasite count
- Africa led the malaria
diagnostics market in 2018 due to high disease incidence and increased
adoption of various malarial diagnostic techniques in the region
- Southeast Asia also held a
considerable revenue share in 2018 owing to high disease reoccurrence and
initiatives undertaken to curb malarial incidence
- Few key companies include
Access Bio, Inc.; Alere, Inc.; Premier Medical Corporation Ltd.; Sysmex
Partec GmbH; bioMérieux, Beckman Coulter, Inc.; Siemens Healthcare; and
Leica Microsystems
Request a Sample Copy of the Report @
https://www.grandviewresearch.com/industry-analysis/malaria-diagnostics-market/request/rs1
Grand View Research has segmented
the global malaria diagnostics market on the basis of technology and region:
Malaria
Diagnostics Technology Outlook (Revenue, USD Million, 2015 - 2026)
- Microscopy
- Rapid Diagnostic Tests
(RDTs)
- Molecular Diagnostic Tests
- Conventional PCR
- Real-Time PCR (qPCR)
Malaria
DiagnosticsRegional Outlook (Revenue, USD Million, 2015 - 2026)
- Africa
- Nigeria
- Democratic Republic of
Congo
- Uganda
- Southeast Asia
- India
- Myanmar
- Indonesia
- Eastern Mediterranean
- Saudi Arabia
- Pakistan
- Western Pacific
- China
- Papua New Guinea
- Cambodia
- Americas
- Venezuela
- Brazil
- Colombia
- Europe
- Turkey
- France
- U.K.
- Germany
About Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, we offer
market intelligence studies ensuring relevant and fact-based research across a
range of industries, from technology to chemicals, materials and healthcare.
For more info visit @ https://www.grandviewresearch.com
No comments:
Post a Comment